Clinical Guidelines for Psychiatrists for the Use of Pharmacogenetic Testing for CYP450 2D6 and CYP450 2C19
De Leon, J. et al. Psychosomatics 47:1 75-85 (2006).
Drug-metabolizing enzymes: Evidence for clinical utility of pharmacogenetic tests
Anderson T. et al. Clinical Pharmacology & Therapeutics, 78:6 559-581 (2005).
Cancer pharmacogenomics: current and future applications Watters JW, McLeod HL Biochim Biophys Acta 2003 Mar 17;1603(2):99-111
Pharmacogenomics study of statin therapy and cholesterol reduction
Chasman DI, et al.
JAMA 2004; 291(23) 2821-2827.
Role of pharmacogenomics in individualising treatment with SSRIs
Mancama D, Kerwin RW
CNS Drugs 2003;17(3):143-51
Cardiovascular pharmacogenomics: current status, future prospects
Anderson JL, Carlquist JF, Horne BD, Muhlestein JB
J Cardiovasc Pharmacol Ther 2003;8(1):71-83
Pharmacogenomics — Drug disposition, drug targets, and side effects
Evans, WE, and McLeod, HL
NEJM 2003; 348:538-549
Inheritance and Drug Response, New England Journal of Medicine
The Dosing of Atypical Antipsychotics, Psychosomatics
Genes and Drug Response, New England Journal of Medicine
Genomic Medicine – A Primer, New England Journal of Medicine
Pharmacogenomics -Drug Disposition, Drug Targets, and Side Effects, New England Journal of Medicine
Pharmacogenomics: Bench to Bedside, Nature
by Sheldon H. Preskorn, M.D. and Anne T. Harvey, Ph.D.
Antidepressant Drug Interactions in the Elderly by Roger J. Cadieux, MD. Understanding the P-450 system is half the battle in reducing risks.
Application of Pharmacogenomics in Clinical Pharmacology, Toxicology Mechanisms and Methods
